VEGF Targeting Agents in Ovarian Cancer

Cód QR

VEGF Targeting Agents in Ovarian Cancer

None

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Mabuchi, Seiji, Wakabayashi, Atsuko, Kimura, Tadashi
Formáid:	Leictreonach Caibidil leabhair
Teanga:	Béarla
Foilsithe / Cruthaithe:	IntechOpen 2012
Ábhair:	Health Sciences
Rochtain ar líne:	https://www.intechopen.com/chapters/28409
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Autotaxin – A Target for the Treatment of Drug-Resistant Ovarian Cancer?
de réir: King-Underwood, John, et al.
Foilsithe / Cruthaithe: (2012)

Beyond VEGF: The NOTCH and ALK1 Signaling Pathways as Tumor Angiogenesis Targets
de réir: Nolan-Stevaux, Olivier, et al.
Foilsithe / Cruthaithe: (2012)

The Role of VEGF in the Process of Neovasculogenesis
de réir: Sobczyńska-Rak, Aleksandra
Foilsithe / Cruthaithe: (2012)

Inflammation and Ovarian Cancer
de réir: Macciò, Antonio, et al.
Foilsithe / Cruthaithe: (2012)

Myeloid-derived suppressor cells and their role in gynecological malignancies
de réir: Seiji Mabuchi, et al.
Foilsithe / Cruthaithe: (2018-08-01)

Neoadjuvant Chemotherapy in Ovarian Cancer
de réir: Singh, Jasmeet Chadha, et al.
Foilsithe / Cruthaithe: (2012)

Epidemiology and Etiology of Ovarian Cancer
de réir: Montes, Ana Fernández, et al.
Foilsithe / Cruthaithe: (2012)

Apoptosis Pathways in Ovarian Cancer
de réir: Sers, Christine, et al.
Foilsithe / Cruthaithe: (2012)

Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor (EGF) in Papillary Thyroid Cancer
de réir: Konturek, Aleksander, et al.
Foilsithe / Cruthaithe: (2012)

Clinical and laboratory significance of soluble claudin-5 and VEGF in ovarian cancer
de réir: N. E. Kushlinskii, et al.
Foilsithe / Cruthaithe: (2025-04-01)

Can VEGF-B Be Used to Treat Neurodegenerative Diseases?
de réir: Li, Xuri, et al.
Foilsithe / Cruthaithe: (2011)

MALDI-MSI and Ovarian Cancer Biomarkers
de réir: Longuespee, Rémi, et al.
Foilsithe / Cruthaithe: (2012)

Dysregulated TGFB Signaling in Ovarian Cancer
de réir: Bauckman, Kyle, et al.
Foilsithe / Cruthaithe: (2012)

Potential Tumor Biomarkers for Ovarian Cancer
de réir: Serio, Ryan, et al.
Foilsithe / Cruthaithe: (2012)

P53 Network in Ovarian Cancer
de réir: Moretti, Fabiola, et al.
Foilsithe / Cruthaithe: (2012)

Ectoenzymes in Epithelial Ovarian Carcinoma: Potential Diagnostic Markers and Therapeutic Targets
de réir: Buono, Nicola Lo, et al.
Foilsithe / Cruthaithe: (2012)

Nasopharyngeal Carcinoma: The Role for Chemotherapeutics and Targeted Agents
de réir: Knol, Jared, et al.
Foilsithe / Cruthaithe: (2012)

Role of EG-VEGF in Human Placentation: Physiological and Pathological Implications
de réir: Hoffmann, P., et al.
Foilsithe / Cruthaithe: (2012)

Combined Therapies to Treat CNV in AMD: PDT + Anti-VEGF
de réir: Mataix, Jorge, et al.
Foilsithe / Cruthaithe: (2012)

Promising Treatment Strategies for Neovascular AMD: Anti-VEGF Therapy
de réir: Park, Young Gun, et al.
Foilsithe / Cruthaithe: (2012)

Endometriosis-Associated Ovarian Cancer: The Role of Oxidative Stress
de réir: Yamashita, Yoriko, et al.
Foilsithe / Cruthaithe: (2012)

Potential Monoclonal Antibody Therapy for the Treatment of Ovarian Cancer
de réir: Lee, Gregory, et al.
Foilsithe / Cruthaithe: (2012)

Chemotherapy-Related Amenorrhea in Breast Cancer: Review of the Main Published Studies, Biomarkers of Ovarian Function and Mechanisms Involved in Ovarian Toxicity
de réir: Berliere, M., et al.
Foilsithe / Cruthaithe: (2011)

Inhibition of Tumor Growth and Metastasis by a Combination of Anti-VEGF-C and Enhanced IL-12 Therapy in an Immunocompetent Mouse Mammary Cancer Model
de réir: Shibata, Masa-Aki, et al.
Foilsithe / Cruthaithe: (2011)

The Role of Prophylactic Oophorectomy in the Management of Hereditary Breast & Ovarian Cancer Syndrome
de réir: Lowery, A.J., et al.
Foilsithe / Cruthaithe: (2012)

Photonic Sensor System for Screening Serum Biomarker Proteins in Ovarian Cancer
de réir: Wawro, Debra, et al.
Foilsithe / Cruthaithe: (2012)

The Role of MUC16 Mucin (CA125) in the Pathogenesis of Ovarian Cancer
de réir: Rancourt, Claudine, et al.
Foilsithe / Cruthaithe: (2012)

New Tumor Biomarkers in Ovarian Cancer and Its Prognostic and Clinical Relevance
de réir: Banys, Malgorzata, et al.
Foilsithe / Cruthaithe: (2012)

Breast and Ovarian Cancer Treatment: Facing Forward Women's Health Care
de réir: Herlinger, Alice Laschuk, et al.
Foilsithe / Cruthaithe: (2011)

The Different Effects of TGF-β1, VEGF and PDGF on the Remodeling of Anterior Cruciate Ligament Graft
de réir: Yu, Changlong, et al.
Foilsithe / Cruthaithe: (2011)

Medicinal and Edible Plants as Cancer Preventive Agents
de réir: Yasukawa, Ken
Foilsithe / Cruthaithe: (2012)

Ovarian Follicular Atresia
de réir: Townson, David H., et al.
Foilsithe / Cruthaithe: (2012)

ErbB2/HER2: Its Contribution to Basic Cancer Biology and the Development of Molecular Targeted Therapy
de réir: Yamamoto, Tadashi, et al.
Foilsithe / Cruthaithe: (2011)

Targeted Apoptosis in Breast Cancer Immunotherapy
de réir: Jia, Lin-Tao, et al.
Foilsithe / Cruthaithe: (2012)

New Targets for Therapy in Pancreatic Cancer
de réir: Tinari, Nicola, et al.
Foilsithe / Cruthaithe: (2012)

Sensitive Detection of Epithelial Ovarian Cancer Biomarkers Using Tag-Laser Induced Breakdown Spectroscopy
de réir: Markushin, Yuri, et al.
Foilsithe / Cruthaithe: (2012)

Transcriptomic Analysis of Human Ovarian Cancer Cells: Changes Mediated by Luteinizing Hormone Receptor Activation
de réir: Cui, Juan, et al.
Foilsithe / Cruthaithe: (2012)

Nanobody, New Agent for Combating Against Breast Cancer Cells
de réir: Rahbarizadeh, Fatemeh, et al.
Foilsithe / Cruthaithe: (2011)

Targeting Tumor Microenvironments for Cancer Prevention and Therapy
de réir: Yang, Li V., et al.
Foilsithe / Cruthaithe: (2012)

Molecular Targets of Benzyl Isothiocyanates in Pancreatic Cancer
de réir: Boreddy, Srinivas Reddy, et al.
Foilsithe / Cruthaithe: (2012)